Heromycin Pharma Co.,ltd. is a Company Limited, established on 16 Jul 2002 and registered in Bangkok, Thailand. The Company’s principal business is manufacture of pharmaceuticals, medicinal chemical products. Heromycin Pharma Co.,ltd. has been operating for 24 years and its current status is Active.
Profile
Company DetailsCompany record
- Legal name
- Heromycin Pharma Co.,ltd.
- Registration number
- 0105545073531
- Entity type
- Company Limited
- Status
- Active
- Registered date
- 16 Jul 2002
- Registered capital (THB)
- THB 27,000,000
- Industry group
- Manufacturing
- TSIC activity
- Manufacture of pharmaceuticals, medicinal chemical products
Contact DetailsRegistered contact information
- Registered address
- 537/2,537/263, Sathu Pradit, Chong Nonsi, Yan Nawa, Bangkok 10120
- Operational address
- Locked🔒
- Website
- Locked🔒
- Telephone
- Locked🔒
People
ManagementRecorded directors and signatory
- Kiatfa LauhapronsawanDirector
ShareholderShareholding of Heromycin Pharma Co.,ltd.
Ownership records and shareholder relationships require premium access.
- ✓Shareholder names and holdings
- ✓Ownership percentages and changes
Financial
Credit RatingCredit rating for Heromycin Pharma Co.,ltd.
Credit assessment and supporting financial indicators require premium access.
- ✓Credit rating and payment profile
- ✓Financial strength and risk indicators
Risk
Government ConnectionGovernment connection checks for Heromycin Pharma Co.,ltd.
Government ownership, control, and politically exposed person links require premium access.
- ✓Government ownership and control checks
- ✓Politically exposed person links
Litigation checks for Heromycin Pharma Co.,ltd.
Court records and material dispute intelligence require premium access.
- ✓Civil and commercial court records
- ✓Case status and material outcomes
Regulatory checks for Heromycin Pharma Co.,ltd.
Regulatory actions, sanctions, and compliance findings require premium access.
- ✓Regulatory actions and sanctions
- ✓Licence and compliance findings
Adverse media checks for Heromycin Pharma Co.,ltd.
Source-screened media coverage and reputational risk signals require premium access.
- ✓Source-screened media coverage
- ✓Material allegations and reputational signals
